FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 355:1497-1500 October 5, 2006 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Marenzi, G. PubMed Citation

To the Editor: The primary end point of the study by Marenzi et al. (June 29 issue)¹ was the occurrence of contrast-medium–induced nephropathy, defined as an increase in the serum creatinine concentration of 25% or more from the baseline value within the 72-hour period after primary angioplasty. The reported incidence of contrast-medium–induced nephropathy varies widely among studies, since increases in the level of serum creatinine and the interval after the administration of contrast medium are not uniform among studies. In the Rapid Protocol for the Prevention of Contrast-Induced Renal Dysfunction (RAPPID) trial,² contrast-medium–induced nephropathy was defined as a 25% increase . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.